1. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198. PMID:
1202204.
2. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922–935. PMID:
1512391.
3. Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Eijk JT. Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. Int J Geriatr Psychiatry 1997;12:101–108. PMID:
9050431.
4. Geslani DM, Tierney MC, Herrmann N, Szalai JP. Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dement Geriatr Cogn Disord 2005;19:383–389. PMID:
15802914.
5. Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 2005;162:667–675. PMID:
15800137.
6. Royall DR, Mahurin R. EXIT, QED, and DSM-IV: very early Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1994;6:62–65. PMID:
8148642.
7. Gleichgerrcht E, Roca M, Manes F, Torralva T. Comparing the clinical usefulness of the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS) and the Frontal Assessment Battery (FAB) in frontotemporal dementia. J Clin Exp Neuropsychol 2011;33:997–1004. PMID:
21923634.
8. Oguro H, Yamaguchi S, Abe S, Ishida Y, Bokura H, Kobayashi S. Differentiating Alzheimer's disease from subcortical vascular dementia with the FAB test. J Neurol 2006;253:1490–1494. PMID:
17041740.
9. Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS. Neuropsychological Assessment. 4th Edition. New York: Oxford University Press; 2004.
10. Nutter-Upham KE, Saykin AJ, Rabin LA, Roth RM, Wishart HA, Pare N, et al. Verbal fluency performance in amnestic MCI and older adults with cognitive complaints. Arch Clin Neuropsychol 2008;23:229–241. PMID:
18339515.
11. McDowd J, Hoffman L, Rozek E, Lyons KE, Pahwa R, Burns J, et al. Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease. Neuropsychology 2011;25:210–225. PMID:
21381827.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth edition. Washington, DC: American Psychiatric Association; 1994.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–944. PMID:
6610841.
14. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260. PMID:
8094895.
15. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863–1872. PMID:
16237129.
16. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–1554. PMID:
9855500.
17. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–246. PMID:
15324367.
18. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412–2414. PMID:
8232972.
19. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part I Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159–1165. PMID:
2771064.
20. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:P47–P53. PMID:
11773223.
21. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–843. PMID:
6878708.
22. Standish TI, Molloy DW, Cunje A, Lewis DL. Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia? Int J Geriatr Psychiatry 2007;22:189–194. PMID:
16977680.
23. Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC, et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology 2004;63:2341–2347. PMID:
15623697.
24. Kemper S, McDowd J. Dimensions of Cognitive Aging: Executive Function and Verbal Fluency. In: Hofer SM, Alwin DF, editor. Handbook of Cognitive Aging: Interdisciplinary Perspectives. Thousand Oaks, CA: Sage, 2008, p. 181
25. Mayr U, Kliegl R. Complex semantic processing in old age: does it stay or does it go? Psychol Aging 2000;15:29–43. PMID:
10755287.
26. Perry RJ, Watson P, Hodges JR. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia 2000;38:252–271. PMID:
10678692.
27. Amieva H, Phillips LH, Della Sala S, Henry JD. Inhibitory functioning in Alzheimer's disease. Brain 2004;127:949–964. PMID:
14645147.
28. Lipton AM, Ohman KA, Womack KB, Hynan LS, Ninman ET, Lacritz LH. Subscores of the FAB differentiate frontotemporal lobar degeneration from AD. Neurology 2005;65:726–731. PMID:
16157906.
29. Slachevsky A, Villalpando JM, Sarazin M, Hahn-Barma V, Pillon B, Dubois B. Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. Arch Neurol 2004;61:1104–1107. PMID:
15262742.
30. Srinivasan S. The concise cognitive test for dementia screening: reliability and effects of demographic variables as compared to the mini mental state examination. Neurol India 2010;58:702–707. PMID:
21045491.
31. Solomon PR, Hirschoff A, Kelly B, Relin M, Brush M, DeVeaux RD, et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol 1998;55:349–355. PMID:
9520009.
32. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–699. PMID:
15817019.
33. Meulen EF, Schmand B, van Campen JP, de Koning SJ, Ponds RW, Scheltens P, et al. The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry 2004;75:700–705. PMID:
15090563.
34. Dong Y, Lee WY, Basri NA, Collinson SL, Merchant RA, Venketasubramanian N, et al. The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatr 2012;24:1749–1755. PMID:
22687278.
35. Lee JY, Lee DW, Cho SJ, Na DL, Jeon HJ, Kim SK, et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2008;21:104–110. PMID:
18474719.